Hemoglobin stability and patient satisfaction after switch to C.E.R.A. therapy: a multicenter, observational study
- PMID: 24129666
- DOI: 10.1007/s40261-013-0142-5
Hemoglobin stability and patient satisfaction after switch to C.E.R.A. therapy: a multicenter, observational study
Comment on
-
Monthly administration of a continuous erythropoietin receptor activator provides efficient haemoglobin control in non-dialysis patients during routine clinical practice: results from the non-interventional, single-cohort, multicentre, SUPRA study.Clin Drug Investig. 2012 Feb 1;32(2):99-110. doi: 10.2165/11594040-000000000-00000. Clin Drug Investig. 2012. PMID: 22117178 Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
